Virtual cell/virtual cell like: The key to unlocking a new era of HIV/AIDS treatment ?

Virtual Cell (VC) technology, as an interdisciplinary frontier at the intersection of systems biology and computational biology, aims to precisely simulate cellular biological behaviors through computer models. This paper systematically explores the potential applications of virtual cell technology in the study of Human Immunodeficiency Syndrome (AIDS), the current key challenges, and future development directions. By reviewing existing literature and research findings, we find that while the term "Virtual Cell" has not been widely and standardized applied in Human Immunodeficiency Virus (HIV) research, its core concept simulating HIV infection, immune responses, and therapeutic interventions through multi-scale, multi-modal computational models has deeply rooted in the forefront of this field. This paper will focus on analyzing the potential of "virtual cell-like" (VCL) models, such as agent-based models, cellular automata, mechanistic mathematical models, etc. in revealing HIV pathogenesis, accelerating drug development and evaluating treatment strategies, and promoting personalized precision medicine. Simultaneously, this paper will explore the technical challenges in practical applications, such as model complexity and biological fidelity, data integration and validation standards, computational resource demands, and ethical dilemmas such as data privacy, clinical decision reliability, and regulatory framework gaps. Finally, we look forward to the integration of artificial intelligence (AI) and virtual cell models, emphasizing the importance of establishing standardized validation processes and ethical governance frameworks to promote the healthy development of this technology and ultimately contribute to conquering HIV/AIDS.